Coronavirus disease 2019 (COVID‐19) is a virus‐induced respiratory disease that may
progress to acute respiratory distress syndrome (ARDS) and is triggered by …

White blood cells (WBCs) are a major component of immunity in response to pathogen
invasion. Neutrophils are the most abundant WBCs in humans, playing a central role in …

Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak
has caused devastating mortality and posed a great threat to public health. However, efforts …

While the mammalian macrophage phenotypes have been intensively studied in vitro, the
dynamic of their phenotypic polarization has never been investigated in live vertebrates. We …

Coronavirus disease-2019 (COVID-19) is a novel respiratory disease induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It remains poorly understood how …

Up to 10–20% of patients with coronavirus disease 2019 (COVID‐19) develop a severe
pulmonary disease due to immune dysfunction and cytokine dysregulation. However, the …

In the 20th century, research focused on cholesterol and lipoproteins as the key mechanism
in establishing atherosclerotic cardiovascular disease (ASCVD). Given that some studies …

ABSTRACT 17β-Estradiol (E2) treatment limits the pathology associated with pulmonary
diseases caused by pathogens, allergens, and asthma, partly by reducing the production of …

Cell surface mucin (cs-mucin) glycoproteins are constitutively expressed at the surface of
respiratory epithelia where pathogens such as influenza A virus (IAV) gain entry into cells …

Multidrug‐resistant Klebsiella pneumoniae (MRKP) has steadily grown beyond antibiotic
control. However, a bacteriophage is considered to be a potential antibiotic alternative for …